EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR/Cas12a Collateral Cleavage Activity for Sensitive 3′–5′ Exonuclease Assay

Jae Hoon Jeung iD, Hyogu Han iD, Chang Yeol Lee iD, Jun Ki Ahn iD

Biosensors · 2023

DOI: 10.3390/bios13110963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2023. Verfasst von Jae Hoon Jeung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Material & Component Convergence R&D Department, Korea Institute of Industrial Technology (KITECH), Ansan 15588, Republic of Korea. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Biosensing Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Industrial Technology, Ministry of Agriculture, Food and Rural Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents a technique for detecting 3′–5′ exonuclease activity through the use of CRISPR/Cas12a. These enzymes, including 3′–5′ exonuclease (Exo III), perform crucial roles in various cellular processes and are associated with life expectancy. However, imbalances in their expression can increase susceptibility to diseases such as cancer, particularly under prolonged stress. In this study, an activator sequence of CRISPR/Cas12a was constructed on the 5′–end of a hairpin probe (HP), forming a blunt end. When the 3′–end of the HP was hydrolyzed with Exo III activity, the activator sequence of Cas12a was exposed, which led to collateral cleavage of the DNA signal probe and generated a fluorescent signal, allowing sensitive and highly specific Exo III detection. This detection principle relied on the fact that Exo III exclusively cleaves the 3′–end mononucleotide of dsDNA and does not affect ssDNA. Based on this strategy, Exo III activity was successfully assayed at 0.0073 U/mL, demonstrating high sensitivity. In addition, this technique was used to screen candidate inhibitors of Exo III activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsBiosensing TechniquesPhosphodiesterase IExodeoxyribonucleasesLimit of DetectionDNADNA Probes

Stichwörter der Autor:innen

CRISPR/Cas12aExonuclease IIIbiosensorcollateral cleavagehairpin probe

Substanzen

Phosphodiesterase IExodeoxyribonucleasesDNADNA Probes

Autor:innen und Institutionen

  • Material & Component Convergence R&D Department, Korea Institute of Industrial Technology (KITECH), Ansan 15588, Republic of Korea.
  • Department of Biological Engineering, College of Engineering, Konkuk University, Seoul 05029, Republic of Korea.
  • Department of Chemistry, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
  • Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.

ORCID-Profile: Jae Hoon Jeung, Hyogu Han, Chang Yeol Lee, Jun Ki Ahn

Förderung

  • Korea Institute of Industrial Technology
  • Ministry of Agriculture, Food and Rural Affairs

Zitieren

APA

Jeung, J. H., Han, H., Lee, C. Y., & Ahn, J. K. (2023). CRISPR/Cas12a Collateral Cleavage Activity for Sensitive 3′–5′ Exonuclease Assay. Biosensors. https://doi.org/10.3390/bios13110963

Vancouver

Jeung JH, Han H, Lee CY, Ahn JK. CRISPR/Cas12a Collateral Cleavage Activity for Sensitive 3′–5′ Exonuclease Assay. Biosensors. 2023. doi:10.3390/bios13110963

BibTeX
@article{Jeung2023,
  author = {Jeung, Jae Hoon and Han, Hyogu and Lee, Chang Yeol and Ahn, Jun Ki},
  title = {CRISPR/Cas12a Collateral Cleavage Activity for Sensitive 3′–5′ Exonuclease Assay},
  journal = {Biosensors},
  year = {2023},
  doi = {10.3390/bios13110963}
}
Kostenlos starten →